CTOR vs MKTX · $105.2M cap vs P/E 13, rev $817.1M
Citius Oncology, Inc. (CTOR) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
CTOR does not have a complete income-statement cache yet.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
CTOR currently screens at market cap $105.2M. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the CTOR and MKTX stock pages for the full models.
Not investment advice.